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Background: Mutations in the cyclin-dependent kinase-like 5 (CDKL5) (NM_003159.2) gene have been associated
with early-onset epileptic encephalopathies or Hanefeld variants of RTT(Rett syndrome). In order to clarify the CDKL5
genotype-phenotype correlations in Chinese patients, CDKL5 mutational screening in cases with early-onset
epileptic encephalopathies and RTT without MECP2 mutation were performed.
Methods: The detailed clinical information including clinical manifestation, electroencephalogram (EEG), magnetic
resonance imaging (MRI), blood, urine amino acid and organic acid screening of 102 Chinese patients with early-onset
epileptic encephalopathies and RTT were collected. CDKL5 gene mutations were analyzed by PCR, direct sequencing
and multiplex ligation-dependent probe amplification (MLPA). The patterns of X-chromosome inactivation (XCI) were
studied in the female patients with CDKL5 gene mutation.
Results: De novo CDKL5 gene mutations were found in ten patients including one missense mutation (c.533G > A, p.
R178Q) which had been reported, two splicing mutations (ISV6 + 1A > G, ISV13 + 1A > G), three micro-deletions
(c.1111delC, c.2360delA, c.234delA), two insertions (c.1791 ins G, c.891_892 ins TT in a pair of twins) and one nonsense
mutation (c.1375C > T, p.Q459X). Out of ten patients, 7 of 9 females with Hanefeld variants of RTT and the remaining 2
females with early onset epileptic encephalopathy, were detected while only one male with infantile spasms was
detected. The common features of all female patients with CDKL5 gene mutations included refractory seizures starting
before 4 months of age, severe psychomotor retardation, Rett-like features such as hand stereotypies, deceleration of
head growth after birth and poor prognosis. In contrast, the only one male patient with CDKL5 mutation showed no
obvious Rett-like features as females in our cohort. The X-chromosome inactivation patterns of all the female patients
were random.
Conclusions: Mutations in CDKL5 gene are responsible for 7 with Hanefeld variants of RTT and 2 with early-onset
epileptic encephalopathy in 71 girls as well as for 1 infantile spasms in 31 males. There are some differences in the
phenotypes among genders with CDKL5 gene mutations and CDKL5 gene mutation analysis should be considered in
both genders.
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Mutations in the cyclin-dependent kinase-like 5 gene
(CDKL5, OMIM 300203) have been described in CDKL5-
related disorders including early-onset seizure variant of
rett syndrome and early-onset epileptic encephalopathies
[1]. Although CDKL5 mutation screenings are generally
performed in cohorts of Rett syndrome (RTT) or a variant
of it, individuals with CDKL5 mutation present their
unique characteristics. Intractable epilepsy that resistant
to multiple antiepileptic drugs (AEDs) often starts within
6 months of age and is associated with severe mental re-
tardation without obvious period of regression. Clinical
manifestations of subsequent cases with CDKL5 mutation
closely resemble some features of RTT including hand ste-
reotypies, autistic-like features, scarce acqusition of lan-
guage and concious hand use. Accumulated evidence
show that phenotype of CDKL5-related disorders overlaps
with early-onset seizure variant of RTT (RTT, OMIM
312750) and early-onset epileptic encephalopathies with X-
linked infantile spasms (ISSX,OMIM308350) [2-7]. Now-
adays, the phenotypic spectrum range of CDKL5-related
diseases has expanded. More than 80 mutations in CDKL5
had been reported, in which 10% females were found with
early-onset seizure variant of RTT, early infantile epileptic
encephalopathy-2 and myoclonic encephalopathy [8-10].
Different CDKL5 mutation types include missense muta-
tions, nonsense mutations, splicing mutations and deletion/
insertions causing frameshifts and premature truncation
[11]. Large rearrangement of the CDKL5 gene has been de-
tected by multiple ligation-dependent probe amplification
(MLPA) [7,10,12]. The reported mutations locate almostly
across all exons of CDKL5 gene and disrupt either the cata-
lytic domain or the C-terminus domain of CDKL5 protein.
Recent data suggests that missense mutations located in
the catalytic domain of CDKL5 could exhibit more severe
clinical manifestation than that caused by truncated muta-
tions located in the C-Terminal of CDKL5 [13]. However,
further investigation is still needed to elucidate the rela-
tionship between clinical severity and mutation types and
locations. Although most of the CDKL5 mutations are
found in females, they also present in some males. Recog-
nition of male CDKL5 mutation carriers broadens the
spectrum of CDKL5-related diseases and suggests that
CDKL5 mutation screening should be carried out in both
genders [14].
The purpose of this study is to delineate the clinical
manifestation of Chinese patients with CDKL5-related
diseases, identify the CDKL5 genotype-phenotype correl-
ation in both genders and broaden the spectrum of
CDKL5 mutations. Although information of Japanese
Asian and Indian Asian have been published [14,15], the
similar data are scarce in Chinese Asian. This work is
the first study of CDKL5-related diseases in a large co-
hort of Chinese patients.Methods
Patients
One hundred and two Chinese patients, including 71
females and 31 males, were recruited after informed con-
sent obtained from the parents of the patients. The me-
dian age was 1 year and 4 months (ranged from 1 month
to 12 years). Among them, 64 cases were diagnosed with
early-onset epileptic encephalopathies, including 36 with
infantile spasm, 8 with Ohtahara syndrome, and 20 with
unknown epileptic syndrome. The seizures of the patients
presented within six months of life without known causes
in all cases recruited in our cohort. Thirty-eight cases were
diagnosed with RTT, including 16 with classical RTT, 10
with congenital RTT, 3 with preserved speech variant
RTT and 9 with Hanefeld variant of RTT. MECP2 muta-
tions were negative in all the RTT patients. The clinical in-
formation was collected from family questionnaire as well
as clinicians’ reviews. Laboratory investigations included
blood and urine amino acid and organic acid screening,
brain MRI and electroencephalogram (EEG). Ethical ap-
proval was obtained from Clinical Research Ethics Com-
mittee, Peking University First Hospital.CDKL5 gene mutational analysis
Genomic DNA was extracted from the peripheral blood
leukocytes of the patients and their parents. CDKL5 gene
(NM_003159.2) mutations were analyzed by polymerase
chain reaction (PCR) and direct sequencing. PCR was
carried out in 25 ul reaction system with 2 × GC Buffer I
12.5 ul, deionized H2O 4.5 ul, 5′ primer 2 ul (5Pmol), 3′
primer 2 ul (5Pmol), dNTPs 2ul, platinum rTaq DNA
polymerase (Invitrogen) 1ul and DNA template 1 ul. The
annealing temperature was 59°C for exon1-21 except for
exon 5 with 57°C. Primer sequences and polymerase chain
reaction conditions are available upon request. GenBank
accession number NM_003159.2 was used as the DNA
reference sequence. The nomenclature used follows the
HGVS mutation nomenclature guidelines (www.hgvs.org).
Pathogenicity prediction of previously unreported variants
was performed using Alamut version2.0 (Interactive Bio-
software, Rouen, France). When no mutation was founded,
MLPA (SALSA MLPA kit P189 CDKL5, MRC-Holland,
Amsterdam, Holland) was performed to detect large dele-
tions or duplications of CDKL5 gene, according to the pre-
vious reports [16,17].The pattern of XCI in female patients with CDKL5 mutation
The pattern of XCI was analyzed in the female patients
with CDKL5 gene mutations, according to the proce-
dures described by Allen et al. [18]. XCI was considered
skewed if the ratio was ≥80:20, and considered extremely
skewed if the ratio was ≥85:15.
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CDKL5 gene mutations
De novo CDKL5 gene mutations were found in ten patients
including one missense mutation (c.533G >A, p.R178Q)
which had been reported, two splicing mutations (ISV6 +
1A >G, ISV13 + 1A >G), three micro-deletion (c.1111delC,
c.2360delA, c.234delA), two insertions (c.1791 ins G,
c.891_892 ins TT in a pair of twins) and one nonsense mu-
tation (c.1375C >T, p.Q459X). Among the ten patients,
nine were females (12.6%, 9/71) and one was male (3.22%,
1/31). The mutation rate was 9.8% (10/102). Out of the pa-
tients who carried a mutation, one male (2.77%, 1/36) case
was diagnosed with infantile spasm, followed by seven
female (77.7%, 7/9) with the Hanefeld variant of RTT, two
female (10%, 2/20) with unknown epileptic syndrome and
none (0%, 0/8) with Ohtahara syndrome. No mutation was
found in their parents (Table 1).
XCI pattern
All the nine female patients with CDKL5 gene mutations
had random X chromosome inactivation. The ratios were
50:50, 63:37, 55:45, 53:47, 58:42, 60:40, 56:44, 52:48 and
54:46, respectively (shown in Table 1).Clinical manifestation
Among the ten patients with CDKL5 gene mutation in the
cohort, phenotype consisted of 7 females with Hanefeld
variant of RTT, 1 male with infantile spasms and 2 females
with early onset epileptic encephalopathy at the first refer-
ral. All the ten patients were attacked by early onset sei-
zures before 4 months of age (from 10 days to 100 days
after birth). Various seizure types presented in the course
of the disease including epileptic spasms, partial seizure,
myoclonic seizure and tonic seizure. However, all the pa-
tients were initially attacked by partial seizure, and then it
transformed to spasm or to the case that including both
partial seizure and spasm after a period of time (10 days to
2.4 years). In the follow-up evaluation, myoclonic seizure
and tonic seizure presented together with the original seiz-
ure types in two patients. All types of seizure in the pa-
tients with CDKL5 gene mutation were intractable and
resistant to the antiepileptic drugs (AEDs). Hypsarrhyth-
mia was identified on EEG records in five patients. Some
Rett-like features presented in 9 female patients, such as
the presence of hand-mouthing, hand washing or clap-
ping became apparent in the first year of life in all of the
female patients. All the patients with CDKL5 mutation
showed severe psychmotor developmental delay. In
addition, hypotonia, poor to absent acquisition of lan-
guage, limited hand skills, poor eye contact, autonomic
dysfunction features and autistic symptoms were the
common features in all the patients. MRI, blood and
urine amino acid and organic acid were normal in allthe patients. Detailed information may be found online
in the supporting information part (Additional file 1).
Discussion
Kalscheuer reported two unrelated girls with infantile
spasms and mental retardation whose CDKL5 gene were
disrupted by different balanced X-autosome translocations
in 2003 [19]. Since then, only about 80 cases with CDKL5
mutations have been reported around the world. The pa-
tients have various phenotypes including early-onset seizure
variant of RTT, X-linked infantile spasms, early infantile
epileptic encephalopathy-2, autism spectrum disorders
(ASDs) and Rett-like syndrome or Angleman-like syn-
drome [20-24].
In this paper, we submit a report on ten more cases of
CDKL5-related diseases, which is the first report on
Chinese asian. Nine females and one male with CDKL5
gene mutations are found in 102 patients with early-
onset epileptic encephalopathy and RTT. The overall
mutation rate of CDKL5 is 9.8% (10/102), which is simi-
lar to that of previous studies [6,9,14]. Among the pa-
tients with CDKL5 gene mutations, 2 are diagnosed
with early onset epileptic encephalopathy, 1 with infantile
spasms and 7 with early-onset seizure of RTT syndrome
when they were first referred to the clinician. It is worth
noting that the two females with early onset epileptic en-
cephalopathy present many characteristics of early-onset
seizure of RTT syndrome in the follow-up assessment. The
CDKL5 gene mutations in our patients include missense
mutation (1/10), nonsense mutation (1/10), splicing muta-
tions (2/10) and insertion/deletion mutation (6/10) causing
frameshifts. No large rearrangement of the CDKL5 gene is
found. All the mutations are proved to be de novo, and no
mutations are further detected in their parents. Among the
detected mutations in this paper, p.R178Q carried by a boy
and a splicing mutation IVS6 + 1G >A carried by a girl are
reported previously [3,4,16,21].
Epilepsy is the core symptom of the patients with
CDKL5 mutation. Bahi-Buisson N [13] concluded three
successive stages of the epilepsy: early epilepsy (onset 1-
10 weeks) with normal interictal EEG (stage I); epileptic
encephalopathy with infantile spasms and hypsarrhythmia
(stage II); refractory tonic seizures and myoclonia (stage
III). In all our patients, the clinical manifestations are sei-
zures, occurring in a range from 10 days to 100 days, the
average of which is 47 days. The initial seizure type of all
the patients is partial seizure. Epileptic spasm presents in
9 patients several days to 2 years after the onset of partial
seizure. Other seizure types including myoclonic seizure,
tonic seizure and atypical absence presents in two patients.
Hypsarrhythmia or atypical hypsarrhythmia are found in
five patients. The epileptic events are resistant to all treat-
ments including the antiepileptic drugs, ACTH and keto-
genic diet. In all our patients, frequent seizure continues
Table 1 Detailed clinical manifestations, mutations and ration of XCI of patients
NO. Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 and 7 Patient 8 Patient 9 Patient 10
Age 2 yrs 3 yrs 3 yrs 4 yrs 5 yrs 2 yrs and 6 mo 5 mo 13mo 2 yrs and 9mo
Gender F F F F F F M F F
Seizure onset 22 ds 10 ds 1.2 mo 3.3 mo 1 mo 2.3 mo 2 mo 1.2 mo 1.3 mo
Partial seizures 22 ds- now 10 ds-2 yrs 1.2 mo- now 3.3 mo-3 yrs 1 mo-now 2.3 mo-now 2 mo-now 1.2 mo-now 1.3 mo-now
Spasm 2.2 mo-now 2 mo-now 1.5 mo-now 3.7 mo-3 yrs 1.5 yrs-now 3 mo-now 2 mo-now - 2.5 yrs-now
Myoclonic seizures - 2 yrs-now - - - - - - 2.8 yrs-now
Tonic seizures - 2 yrs-now - - - - - - 2.8 yrs-now
Drug resistance + + + + + + + + +
Hypsarrhythmia - + - - + + + - -
Deceleration of head growth + + + + + + + + +
Hypotonia + + + + + + + + +
Limited hand skills + + + + + + + + +
Stereotypies + + + + + + - + +
Sit unaided 16 mo 11 mo 18 mo 24 mo 6 mo 6 mo - - -
Walk (ever) - - - - A few steps _ - - -
Speech Absent One word Absent Absent Absent Absent Absent Absent Absent
Autistic featuresa + + + + + + + + +
Autonomic featuresb NA + NA + + + - + +
MRI or CT - - - - - - - - -
CDKL5 mutations c.1111 delC ISV13 + A > G c.1791 insG ISV6 + 1A > G c.1375C > T; c.891_892ins TT c.533G > A; c.2360delA c.234delA
Position of mutatins C-terminal C-terminal C-terminal Catalytic domain C-terminal Catalytic domain Catalytic domain C-terminal Catalytic domain
XCI ratio 50:50 63:37 55:45 53:47 58:42 60:40/56:44 - 52:48 54:46
Abbreviations: EOEE, early onset epileptic encephalopathy; Hanefeld RTT, Hanefeld variant of Rett syndrome; IS, infantile spasms; F, female; M, male; yrs, years; mo, months; ws, weeks; ds, days; HC, head circumference;
cm, centimeter; NA, nonavailable.
aautistic features include avoidance of eye gazing, reduced social interaction.
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was seizure-free 3-years later.
All the patients show severe psychmotor developmental
delay. Seven patients could sit unaided, the time delayed
in 6 patients is in the range from 8 months to 24 months,
the average which is 12.5 months. The other three cases
aged from 5 months to 2 years and 9 months could not sit
at all. Nine patients could not walk. All the female patients
with CDKL5 mutation show some Rett-like features such
as stereotypic hand movements. The presence of hand-
mouthing, hand washing or clapping becomes apparent in
the first year of life in seven patients. In addition, hypo-
tonia, limited hand skills, poor eye contact and autistic
symptoms are the common features of all the patients. Al-
though the symptoms of our patients with CDKL5 muta-
tions overlap with some features of Hanefeld variant of
RTT, recent reports have clarified that CDKL5-related dis-
order should be considered as separate from RTT, rather
than another variant [25,26].
Despite the common features shared by patients with
CDKL5 mutation of both genders, there are some pheno-
typic differences between females and males [3,16]. Seven
males with CDKL5 mutations have been reported so far,
which are much less than females. Bahi-Buisson N con-
ducted a comparison of clinical features between both
genders. The results showed that none of the reported
males acquired language skills (0% vs 12.3%) or ambula-
tion with or without aid (0% vs 32.4% ) compared to fe-
male patients. Of greater interest is that Rett-like features
such as hand stereotypies have scarcely been reported in
males with CDKL5 mutations [3,16,27-29]. In agreement
with the reported male characteristics, the male patient
aged 5 months in our cohort manifests early-onset sei-
zures, hypotonia, poor eye contact and poor response to
antiepileptic drugs. He does not acquire hand skills and
never develop apparent hand stereotypies as female pa-
tients. The clinical manifestations still need further observa-
tions due to the young age of the boy. The most recent
reports indicates that there are no differences in clinical se-
verity between both genders with CDKL5 mutation [8], and
more male cases are necessary to support this conclusion.
CDKL5 encodes a serine threonine kinase protein com-
posed of a catalytic domain and a long C-terminal exten-
sion. Catalytic domain regulates the catalytic activity of
CDKL5 gene and the C-terminal involves in sub-nuclear
localization of the protein and negatively regulates the
catalytic activity [30]. The clinical severity may be associ-
ated with the location and the type of mutations, but the
genotype-phenotype correlation still remains obscure [22].
It has been reported that some recurrent mutations in N-
terminal catalytic domain such as p.Arg59X, p.Arg134X,
p.Arg178Trp/Pro/Gln, c.145 + 2 T > C and frameshift mu-
tations in the C-terminal region such as c.2635_2636del
CT cause more severe phenotype, which is manifested byearlier onset, infantile spasms and hypsarrhythmia, refrac-
tory epileptic encephalopathy, microcephaly, and inability
to walk [31]. The patients with p.Ala40Val mutation which
affects ATP-binding site in catalytic domain, showed mild
phenotype (walked unaided, normocephaly, better hand
use ability, and less frequent refractory epilepsy), com-
pared to those with other CDKL5 mutations [5,6,13].
Russo et al. proposed that patients with stop codon muta-
tions have a milder phenotype than those with missense
or splicing mutations [12]. In our cohort, there are no ob-
vious differences between catalytic domain (patient 4, 6
and 7, 8 and 10) and C-terminal (patient 1, 2, 3, 5 and 9)
domain. Patient 4 with splicing mutation shows seizure-
free after 3-year old. She is the only patient who could
walk a few steps and sit unaided at 6 months. Therefore,
in our study we cannot develop any clear relationship be-
tween the clinical manifestation and the type of CDKL5
mutations, due to the limited number of mutation samples
in our study. The pattern of XCI is known as the import-
ant modulator of the phenotype in X-link genetic diseases.
Kalscheuer VM et al. [19] found that the normal X
chromosome in two females with heterozygous CDKL5
mutations was functionally absent, suggesting CDKL5 lo-
cated in X gene was subject to inactivation in female som-
atic cells. Tao et al. [20] showed that variable expression of
the wild-type CDKL5 allele was associated with intra-
familial phenotypic variability of the disease. However,
both Weaving et al. [21] and Evans JC et al. [3] reported
that twin sisters with the similar XCI pattern in cells from
peripheral blood exhibited completely different clinical
features. Hence, different phenotypes do not appear to be
as a result of X-inactivation status. In this study, all the 9
females with CDKL5mutations have random XCI patterns
and we may conclude that the differences of their clinical
manifestations could not be attributed to XCI. Similar re-
sults are reported in the references [6,9]. It is worth noting
that the XCI pattern in peripheral blood may not necessar-
ily reflect the XCI pattern in neurons. Furthermore, the
distribution of XCI in brain may differ from region to re-
gion due to its tissue-specific variation [32]. Therefore, in
order to develop an effective relationship between the pat-
tern of XCI and clinical manifestations, the above ques-
tions should be addressed first in future.
Conclusions
This study is the first report of Chinese patients with
CDKL5 gene mutations. The common clinical features of
the ten patients with CDKL5 mutations include none or
limited language development, severe hypotonia, deceler-
ation of head growth, hand apraxia and hand stereotypies,
as well as early-onset seizures presented initially as partial
seizures and soon transformed to spasms. CDKL5 mutation
is an important cause in female patients with early onset
epilepsy and severe psychomotor retardation without
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relationship between the clinical manifestation and the type
of CDKL5 mutations as well as the XCI pattern. Complete
screening of CDKL5 exons including MLPA tests should be
performed on both genders, although large rearrangement
had not been detected in our cohort.
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Additional file 1: Online supplement detailed clinical
manifestations of the patients with CDKL5 mutation in our cohort.
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